GENENTECH

📅 Upcoming

🕒 Recent(90d)

News

• Supernus, Indivior merger expected to result in ‘natural redundancies’
  Follow along as BioSpace tracks job cuts and restructuring initiatives.
  biospace · 20h ago
• Biogen validated the Alzheimer’s tau theory. CEO Viehbacher still isn’t betting the store
  With so many unknowns, Biogen is carefully eyeing its next-gen Alzheimer’s treatment diranersen as a high-risk, high-reward project with the potential for a major payout around 2030.
  biospace · 6d ago
• Webinar: From Clinical to Commercial: Talent Strategies for Biopharma Growth
  This webinar provides an assessment of recent job market activity across biopharma and explores how companies approaching commercial readiness or building out sales and marketing teams can navigate…
  biospace · 13d ago
• Chutes & Ladders—Cue lines up new CMO and research head
  Cue Biopharma is tapping in a new chief medical officer and head of R&D in Dominic Borie, M.D., Ph.D., a physician-scientist with over two decades of industry experience.
  fiercebiotech · 19d ago
• Roche aims to bolster breast cancer pipeline with early-stage Astex deal
  Monday’s deal between Otsuka’s subsidiary Astex Pharmaceuticals and Roche’s subsidiary Genentech is of interest not because it is big money — the upfront fee is just $25 million — but because of wh…
  endpoints · 29d ago
• Ex-iTeos CEO starts fresh at GSK neuro partner; Genentech loses yet another key scientist
  → Michel Detheux has succeeded Rita Balice-Gordon as CEO of Danish neuro biotech Muna Therapeutics, which is partnering with GSK on Alzheimer’s treatments. Balice-Gordon will slide over to ...
  endpoints · 1mo ago
• FDA Approves First Single-Dose Generic Treatment for Influenza
  The U.S. Food and Drug Administration today approved the first generic of Xofluza (baloxavir marboxil) tablets, the first single-dose treatment for acute uncomplicated influenza and prophylaxis in…
  fda_press · 1mo ago
• STAT+: Human Cell Atlas leader’s tie to 10x Genomics raises conflict-of-interest questions
  As the Human Cell Atlas project marks its 10th anniversary, a leader's ties to a major single-cell RNA sequencing company raise conflict-of-interest questions.
  stat · 1mo ago
• Exclusive: Genentech closes infectious disease unit in wave of research layoffs
  Roche's Genentech underwent another round of layoffs this week in its early research and development group, Endpoints News has learned, which included shuttering two research units and the departur…
  endpoints · 1mo ago
• A Spanish biotech banks $87M to make differentiated ADCs
  Ona Therapeutics, a Barcelona-based drugmaker, is developing next-generation drugs it says could help patients with advanced forms of breast and colorectal cancers.
  biopharma_dive · 2mo ago